Heart Disease Trial, Recruiting (NCT05783804)

Heart Disease Trial, Recruiting NCT05783804 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05783804 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with a genetic condition called heterozygous familial hypercholesterolemia (an inherited form of high cholesterol)
Adults aged between 18 and 50 years old
People whose LDL ("bad") cholesterol level is above 100 mg/dL (or above 2.6 mmol/L) at the time of joining the trial

Who may not be able to join:

People with serious kidney problems, where the kidneys are functioning at a significantly reduced level (confirm with trial site)
People who have previously had a heart attack, stroke, or other cardiovascular event related to blocked or hardened arteries
People who have atrial fibrillation (an irregular heartbeat condition)
People who have another medical condition or are receiving another treatment that the trial doctor believes could affect the trial's results or safety
People who are unable or unwilling to follow the trial's requirements, or whom the trial doctor considers unsuitable for participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erik SG Stroes, MD, PhD, Amsterdam UMC, location AMC

Phone: +205669111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05783804

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +205669111

More information: https://clinicaltrials.gov/study/NCT05783804

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with a genetic condition called heterozygous familial hypercholesterolemia (an inherited form of high cholesterol)
Adults aged between 18 and 50 years old
People whose LDL ("bad") cholesterol level is above 100 mg/dL (or above 2.6 mmol/L) at the time of joining the trial

Who may not be able to join:

People with serious kidney problems, where the kidneys are functioning at a significantly reduced level (confirm with trial site)
People who have previously had a heart attack, stroke, or other cardiovascular event related to blocked or hardened arteries
People who have atrial fibrillation (an irregular heartbeat condition)
People who have another medical condition or are receiving another treatment that the trial doctor believes could affect the trial's results or safety
People who are unable or unwilling to follow the trial's requirements, or whom the trial doctor considers unsuitable for participation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Registry

ClinicalTrials.gov

Start date

7 July 2022

Est. completion

1 December 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

CAD Progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov